anmelden
FTSE 100
10.728,04
PKT
+7,74
PKT
+0,07
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu FTSE 100-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 10.02.23 | Unilever Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 10.02.23 | GSK Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 10.02.23 | AstraZeneca Neutral | Credit Suisse Group | |
| 10.02.23 | Glencore Neutral | UBS AG | |
| 10.02.23 | Unilever Underweight | JP Morgan Chase & Co. | |
| 10.02.23 | Unilever Neutral | Goldman Sachs Group Inc. | |
| 09.02.23 | Unilever Sector Perform | RBC Capital Markets | |
| 09.02.23 | BAT Neutral | Goldman Sachs Group Inc. | |
| 09.02.23 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 09.02.23 | Unilever Neutral | Goldman Sachs Group Inc. | |
| 09.02.23 | Unilever Underperform | Bernstein Research | |
| 09.02.23 | Unilever Sell | UBS AG | |
| 09.02.23 | BAT Overweight | JP Morgan Chase & Co. | |
| 09.02.23 | Unilever Sector Perform | RBC Capital Markets | |
| 09.02.23 | AstraZeneca Hold | Jefferies & Company Inc. | |
| 09.02.23 | Unilever Buy | Jefferies & Company Inc. | |
| 09.02.23 | Unilever Underweight | JP Morgan Chase & Co. | |
| 09.02.23 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 08.02.23 | BP Overweight | Barclays Capital | |
| 08.02.23 | BP Hold | Jefferies & Company Inc. | |
| 08.02.23 | BP Conviction Buy List | Goldman Sachs Group Inc. | |
| 08.02.23 | Glencore Outperform | RBC Capital Markets | |
| 08.02.23 | BP Outperform | RBC Capital Markets | |
| 07.02.23 | Diageo Underperform | RBC Capital Markets | |
| 07.02.23 | BP Buy | UBS AG | |
| 07.02.23 | BP Conviction Buy List | Goldman Sachs Group Inc. | |
| 07.02.23 | BP Hold | Jefferies & Company Inc. | |
| 07.02.23 | AstraZeneca Buy | Deutsche Bank AG | |
| 07.02.23 | BP Outperform | RBC Capital Markets | |
| 06.02.23 | Shell (ex Royal Dutch Shell) Buy | Jefferies & Company Inc. | |
| 06.02.23 | Shell (ex Royal Dutch Shell) Buy | UBS AG | |
| 06.02.23 | BAT Outperform | Credit Suisse Group | |
| 06.02.23 | Diageo Outperform | Bernstein Research | |
| 03.02.23 | BP Outperform | RBC Capital Markets | |
| 03.02.23 | Shell (ex Royal Dutch Shell) Outperform | RBC Capital Markets | |
| 03.02.23 | Shell (ex Royal Dutch Shell) Neutral | Goldman Sachs Group Inc. | |
| 03.02.23 | Shell (ex Royal Dutch Shell) Overweight | JP Morgan Chase & Co. | |
| 02.02.23 | Shell (ex Royal Dutch Shell) Outperform | RBC Capital Markets | |
| 02.02.23 | Shell (ex Royal Dutch Shell) Buy | Jefferies & Company Inc. | |
| 02.02.23 | Shell (ex Royal Dutch Shell) Outperform | RBC Capital Markets |
* Die angezeigten Realtime Kurse sind indikativ und nicht die offiziellen Börsenkurse. Die Kursdaten können eventuell vom tatsächlichen Marktpreis abweichen.
